Spectrum Pharmaceutecals Inc (SPPI)

[dcaf7]

More estimates.
Research analysts at Jefferies Financial Group dropped their FY2025 earnings per share (EPS) estimates for shares of Spectrum Pharmaceuticals in a research note issued to investors on Wednesday, February 1st. Jefferies Financial Group analyst M. Raycroft now expects that the biotechnology company will post earnings per share of $0.22 for the year, down from their prior forecast of $0.23. The consensus estimate for Spectrum Pharmaceuticals’ current full-year earnings is ($0.48) per share. Jefferies Financial Group also issued estimates for Spectrum Pharmaceuticals’ FY2026 earnings at $0.27 EPS and FY2027 earnings at $0.33 EPS.